Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
1
-
Total shares
-
8K
-
Shares change
-
-21.8M
-
Total reported value, excl. options
-
$3.56K
-
Value change
-
-$3.76M
-
Number of sells
-
-30
-
Price
-
$0.44
Significant Holders of iBio, Inc. - Common Stock (IBIO) as of Q4 2022
1 filings reported holding IBIO - iBio, Inc. - Common Stock as of Q4 2022.
iBio, Inc. - Common Stock (IBIO) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8K shares
.
Largest 10 shareholders include EDMOND DE ROTHSCHILD HOLDING S.A. (8K shares), Capital Advisory Group Advisory Services, LLC (0 shares), GROUP ONE TRADING, L.P. (0 shares), CITIGROUP INC (0 shares), NORTHERN TRUST CORP (0 shares), MJP ASSOCIATES INC /ADV (0 shares), VANGUARD GROUP INC (0 shares), Avantax Planning Partners, Inc. (0 shares), RENAISSANCE TECHNOLOGIES LLC (0 shares), and US BANCORP \DE\ (0 shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.